立法會衞生事務委員會聚焦流感防控與大灣區醫療合作

本次立法會衞生事務委員會會議主要討論兩大議題：2026/27流感季節準備工作及大灣區醫療合作進展。

在流感防控方面，政府表示本港已進入夏季流感季節，未來數星期流感活躍程度預計持續上升。疫苗接種仍然是最重要的預防措施，但議員普遍關注長者、院舍員工及6個月至2歲幼童的接種率偏低。政府將加強宣傳教育、推動院舍外展接種服務，並優化學校疫苗接種計劃及醫健通電子同意書系統，以提升接種便利性及覆蓋率。

在大灣區醫療合作方面，長者醫療券計劃已擴展至大灣區九個內地城市，累計超過40,600名長者受惠。港大深圳醫院覆診先導計劃、跨境直通救護車服務，以及醫健通跨境病歷互通均取得階段性成果。此外，「港澳藥械通」已批准71種藥物及91種醫療器械於指定機構使用，進一步提升創新醫療服務的可及性。

議員關注長者醫療券是否可擴展至海南及福建等地，以及如何善用大灣區醫療資源。政府重申，跨境醫療旨在為港人提供更多便利和選擇，而非將香港醫療責任轉移至內地。未來將繼續深化跨境病歷互通、創新藥械合作及跨境醫療服務發展。

【LegCo Health Panel Focuses on Flu Prevention and Greater Bay Area Healthcare Collaboration】

The meeting focused on two major topics: preparations for the 2026/27 influenza season and the latest developments in Greater Bay Area (GBA) healthcare collaboration.

Regarding influenza preparedness, the Government reported that Hong Kong has entered the summer influenza season, with influenza activity expected to increase in the coming weeks. Vaccination remains the most effective preventive measure, but Members expressed concerns about the relatively low vaccination rates among the elderly, care home staff and children aged six months to under two years. The Government will strengthen public education, expand outreach vaccination services, enhance school vaccination programmes and further simplify the eHealth electronic consent process to improve vaccine uptake.

On GBA healthcare collaboration, the Elderly Health Care Voucher Scheme has expanded to all nine Mainland GBA cities, benefiting more than 40,600 elderly residents. Significant progress has also been made in the HKU-Shenzhen Hospital Follow-up Consultation Programme, the cross-boundary ambulance transfer service and cross-boundary health record sharing through eHealth. In addition, the Hong Kong-Macau Medicines and Medical Devices Connect Scheme has approved 71 medicines and 91 medical devices for use in designated institutions, improving access to innovative treatments.

Members discussed the possibility of extending the voucher scheme to regions such as Hainan and Fujian and explored ways to better leverage GBA healthcare resources. The Government reiterated that cross-boundary healthcare is intended to provide additional healthcare options and convenience for Hong Kong residents, rather than shift Hong Kong’s healthcare responsibilities to Mainland cities. Future efforts will focus on deeper health record integration, innovative medicine collaboration and the continued development of cross-boundary healthcare services.

醫務衞生局向委員會匯報流感季節應對部署。政府指出，本港今年未出現預期冬季流感高峰，但流感活躍程度自5月起持續上升，6月底已超越基準線，香港正式進入夏季流感季節，預計未來數星期仍有上升趨勢。

疫苗接種仍是防控核心

政府表示，上年度共接種超過203萬劑季節性流感疫苗。數據顯示，未接種疫苗的兒童出現重症或死亡風險約為已接種者的5倍；院舍長者若未接種疫苗，重症風險約為已接種者的4倍。因此，當局將持續推廣接種工作，以降低重症及死亡個案。

長者及幼童接種率成最大關注

多名議員關注長者及幼童接種率偏低問題。65歲以上長者接種率出現下跌，而院舍員工接種率只有約三成，憂慮員工將病毒帶入院舍。另一方面，6個月至未滿2歲幼童接種率約27%，議員認為遠未達理想水平。

政府回應指，將透過母嬰健康院、社區網絡及短訊提示等渠道加強推廣，並向家長及前線醫護提供更多科學數據及資訊，提升接種意願。

院舍員工接種率低引起廣泛關注

議員認為院舍長者接種率相對理想，但員工接種率持續下降，對院友健康構成風險。政府表示將聯同社會福利署加強宣傳，並透過外展接種隊到院舍提供即場服務。有議員建議考慮設立表揚機制或標籤計劃，提高院舍管理層推動員工接種的積極性。

學校外展接種計劃成效理想

目前超過99%學校參與外展接種計劃，僅約18間學校未有參加。噴鼻式流感疫苗接種量較去年增加超過80%。議員關注能否提早於9月開始接種，以及提升家長使用醫健通電子同意書的比率。政府表示將於暑假期間舉辦學校簡介會，並透過社交媒體及家長渠道加強宣傳。

家庭醫生疫苗採購計劃擴大

政府宣布將家庭醫生疫苗採購先導計劃由10萬劑增至30萬劑，並擴大參與資格至更多基層醫療醫生。針對議員關注可能出現濫用或額外收費情況，當局強調計劃規定不得向接種者收取額外費用，並會透過接種紀錄監察及跟進異常情況。

中醫藥角色受關注

有議員建議參考新冠疫情期間安排，以公私營合作方式資助市民到私家中醫求診。政府表示將鼓勵私營中醫增加診症時段，並按需要提升18區中醫診所及香港中醫醫院服務量，但暫未承諾推出額外資助計劃。

醫健通數碼化進一步推進

因應診所過往需處理大量紙本同意書的問題，政府宣布2026/27年度起將優化流程，市民及家長可直接透過醫健通App提交疫苗接種同意書，進一步簡化行政程序，並向診所提供培訓和技術支援。

行動項目 負責單位

向區議會及關愛隊進行流感簡報會 衞生署

加強長者及院舍員工疫苗推廣 衞生署、社署

加強6個月至2歲幼童家長教育工作 母嬰健康院、衞生署

推出醫健通電子同意書功能 醫健通／醫衞局

發放家長使用教學及宣傳材料 衞生署

擴大家庭醫生疫苗採購計劃至30萬劑 醫衞局

與私營中醫業界協調增加流感高峰期服務 中醫藥發展處

研究社區客廳及日間中心外展接種可行性 衞生署（表示會考慮）

持續監察院舍員工接種率 醫衞局、衞生署

總結

整體而言，政府的流感季準備工作重點集中於提升疫苗接種率、擴大接種便利性及推動數碼化流程。議員最關注的議題包括長者及幼童接種率偏低、院舍員工接種不足，以及如何透過學校和社區網絡提升市民參與度。未來數月，政府將加強宣傳、推廣及外展服務，以應對預計持續上升的夏季流感個案。

The Secretary for Health, Professor Lo Chung-mau, briefed Members on the Government’s preparations for the 2026/27 influenza season. The Government noted that the anticipated winter influenza peak did not materialise this year. However, influenza activity has been rising since May and exceeded the baseline level by the end of June, indicating that Hong Kong has entered the summer influenza season. Activity is expected to continue increasing in the coming weeks.

Vaccination Remains the Cornerstone of Prevention

The Government reported that more than 2.03 million doses of seasonal influenza vaccine were administered in the previous season. Vaccination continues to be the most effective measure to prevent severe illness and death.

Data presented showed that:

Unvaccinated children are around five times more likely to develop severe complications or die from influenza compared with vaccinated children.

Unvaccinated elderly residents in care homes face approximately four times the risk of severe illness compared with those who are vaccinated.

Low Vaccination Rates Among the Elderly and Young Children Remain Key Concerns

Members expressed concern over declining vaccination uptake among older adults and persistently low coverage among young children.

Key concerns included:

A decline in vaccination rates among people aged 65 or above.

Care home staff vaccination rates remaining at only about 30%.

Vaccination coverage among children aged 6 months to under 2 years standing at approximately 27%.

Members urged the Government to strengthen public education, improve accessibility and increase awareness among parents and caregivers.

In response, the Government stated that it will:

Strengthen promotion through Maternal and Child Health Centres, district networks and SMS reminders.

Enhance communication on vaccine safety and effectiveness.

Provide frontline healthcare workers with consistent scientific evidence to support vaccination advocacy.

Care Home Staff Vaccination Rates Under Scrutiny

Several Members highlighted the contrast between relatively high vaccination rates among care home residents and the declining rates among care home staff, which may increase the risk of introducing influenza into residential facilities.

The Government indicated that it will:

Work closely with the Social Welfare Department to strengthen outreach and education.

Continue providing on-site vaccination services through outreach teams.

Encourage higher uptake through targeted promotional efforts.

Some Members also suggested introducing recognition schemes or accreditation labels to incentivise care homes to promote staff vaccination.

Strong Performance of the School Outreach Vaccination Programme

The Government reported that more than 99% of schools have joined the School Outreach Vaccination Programme, with only around 18 schools not participating.

In addition:

Uptake of the nasal spray influenza vaccine increased by more than 80% compared with previous years.

Members raised questions about:

Whether vaccinations could begin as early as September.

How to increase awareness and use of the eHealth electronic consent system among parents.

The Government stated that school briefings will be conducted before the new academic year and that promotional campaigns, including step-by-step guidance materials, will be provided through social media and parent networks.

Expansion of the Family Doctor Vaccine Procurement Pilot Scheme

The Government announced that the Family Doctor Vaccine Procurement Pilot Scheme will expand from 100,000 doses to 300,000 doses and will be opened to more primary healthcare practitioners.

Members sought clarification on safeguards against misuse, including the possibility of:

Vaccines being administered outside designated target groups.

Additional administrative or service charges being imposed on recipients.

The Government stressed that:

Participating providers are not permitted to charge additional fees for vaccination under the scheme.

Vaccination records will be monitored and any irregularities investigated.

Role of Chinese Medicine During Influenza Peaks

Members suggested drawing on the public-private collaboration model used during the COVID-19 pandemic by providing subsidised Chinese medicine consultations.

The Government responded that it will:

Encourage private Chinese medicine practitioners to extend service hours during peak periods.

Increase service capacity at district Chinese medicine clinics and the Hong Kong Chinese Medicine Hospital when necessary.

No commitment was made to introduce additional subsidy schemes at this stage.

Pneumococcal and Nasal Spray Vaccines

Members also discussed pneumococcal vaccination and the growing popularity of nasal spray influenza vaccines.

The Government advised that:

Healthy older adults generally require only one dose of pneumococcal vaccine.

Additional doses may be recommended for high-risk individuals based on expert scientific advice.

For nasal spray vaccines:

Usage increased from approximately 27,000 doses to 48,000 doses, representing growth of over 80%.

Both injectable and nasal spray vaccines remain available for kindergarten, primary and secondary school students.

Progress in eHealth Digitalisation

The Government received support for plans to simplify administrative processes through eHealth.

For the 2026/27 season:

Citizens will be able to submit vaccination consent forms directly through the eHealth App.

Parents will be able to submit consent forms for their children in advance.

Reliance on paper forms will be significantly reduced.

Additional training and technical support will be provided to clinics.

Key Takeaway

The Government’s influenza preparedness strategy focuses on increasing vaccination coverage, improving access to vaccination services, strengthening outreach to high-risk groups, and accelerating digitalisation through eHealth. Members’ primary concerns centred on low vaccination rates among the elderly, care home staff and young children. The coming months will see intensified promotion, outreach and service enhancement efforts to mitigate the anticipated rise in summer influenza activity.

醫務衞生局局長盧寵茂教授向委員會介紹近年大灣區醫療合作的主要成果。政府表示，跨境醫療政策旨在便利港人在內地生活及就醫，並非取代香港現有醫療體系，而是透過區域合作提升服務便利性及病人選擇。

長者醫療券及跨境醫療服務持續擴展

長者醫療券大灣區試點計劃已由最初的港大深圳醫院逐步擴展至大灣區九個內地城市，目前共有21個服務點可使用醫療券。截至目前，超過40,600名長者受惠，涉及約101,000宗交易，累計申領金額超過1億港元。

此外，港大深圳醫院覆診先導計劃持續支援居住於廣東省的醫管局病人，至今已有超過6,100名病人參與，累計提供約27,000人次診症服務。政府指出，該計劃最初因應疫情推出，現已成為長居內地港人的重要醫療支援措施。

跨境救護車及病歷互通取得進展

政府於2025年底推出跨境直通救護車試行計劃，截至目前共有29宗個案受惠，包括28宗由內地轉送返港及1宗由香港轉送至珠海。當局強調，該服務屬於「跨境轉院安排」，適用於病情穩定及經醫生評估適合轉送的病人，並非跨境緊急救護服務。

在醫療資訊互聯互通方面，政府已推出醫健通跨境病歷功能，並於2026年起容許部分大灣區醫院將放射影像及檢查報告直接傳送至醫健通系統，被視為跨境病歷共享的重要里程碑。

港澳藥械通及醫療標準合作深化

截至2026年4月，「港澳藥械通」已批准71種藥物及91種醫療器械於大灣區指定醫療機構使用，讓病人更快獲得創新藥物及先進醫療技術。

同時，由香港及內地專家共同制定的國際醫院評審認證標準（中國版）亦逐步推展。目前已有5間醫管局醫院通過認證，另有兩間大型急症醫院將於2026/27年度加入，全國已有約13間醫院獲認證。

議員關注長者醫療券服務體驗及擴展

雖然長者醫療券計劃整體滿意度高達9.15分（10分滿分），議員仍關注部分長者在內地求醫時面對的困難，包括粵語支援不足、不熟悉內地掛號程序、藥物名稱差異，以及醫療券支付流程較複雜等。

部分議員建議將醫療券計劃進一步擴展至海南博鰲醫療特區、福建等港人聚居地。政府表示，未來會根據港人居住分布、服務需求及行政成本等因素作出檢討，但現階段仍以大灣區作為發展重點。

政府重申不會將醫療責任轉移至內地

有議員提出在香港公營醫療壓力增加下，應更積極利用大灣區醫療資源，包括擴展港大深圳醫院服務及採購大灣區放射診斷服務。

對此，盧寵茂局長明確表示，政府無意將照顧香港市民的醫療責任轉移至其他城市。跨境醫療的定位是為港人提供更多便利及選擇，而非以內地醫療服務取代香港醫療體系。至於跨境採購放射診斷服務，政府仍在研究醫療質量、專業資格認可及法律監管等問題。

創新藥物及跨境購藥安排受關注

議員亦關注「港澳藥械通」的審批效率及創新醫療發展。政府表示正籌備成立藥械監督管理中心，並積極增聘相關專業人才，以支持香港發展成為國際醫療創新樞紐。

另外，有議員反映部分癌症及罕見病患者因藥價差異而選擇到內地購藥。政府指出，市民自行到內地求醫或購藥屬個人選擇，香港醫生可提供病歷資料協助診治，但藥物處方及購買安排必須符合兩地法例及監管要求。

總結

整體而言，委員會普遍支持大灣區醫療合作的發展方向，包括長者醫療券試點計劃、港大深圳醫院覆診安排、跨境直通救護車及醫健通病歷互通等措施。政府重申，跨境醫療是對香港醫療服務的補充，而非替代。未來工作重點將集中於進一步完善跨境病歷互通、深化港澳藥械通安排、優化跨境轉院服務，以及研究長者醫療券的進一步擴展空間。

The Government reported significant progress in cross-boundary healthcare cooperation across the Greater Bay Area, with a focus on improving access to healthcare services for Hong Kong residents living or travelling in Mainland China.

Key Developments in Cross-Boundary Healthcare

Expansion of the Elderly Health Care Voucher GBA Pilot Scheme

The Elderly Health Care Voucher Scheme has expanded substantially in recent years. What began at HKU-Shenzhen Hospital has now been extended to all nine Mainland GBA cities, covering 21 service points.

To date:

More than 40,600 elderly Hong Kong residents have benefited.

Over 101,000 healthcare transactions have been completed.

Total claims have exceeded HK$100 million.

HKU-Shenzhen Hospital Follow-up Consultation Pilot Programme

The programme, originally introduced during the COVID-19 pandemic to support patients unable to return to Hong Kong, now mainly serves Hospital Authority patients residing in Guangdong Province.

So far:

More than 6,100 patients have enrolled.

Approximately 27,000 consultations have been provided.

Cross-Boundary Ambulance Transfer Service

Since its launch in November 2025, the direct cross-boundary ambulance pilot scheme has facilitated 29 patient transfer cases:

28 transfers from Mainland China to Hong Kong.

1 transfer from Hong Kong to Zhuhai.

The scheme currently covers designated hospitals in Shenzhen, Zhuhai, Macau and Nansha.

Cross-Boundary Health Record Sharing

The Government highlighted major progress in electronic health record interoperability:

By the end of 2025, all Hong Kong residents could access cross-boundary health record functions through eHealth.

From 2026, selected GBA hospitals have begun transmitting radiology images and reports directly to Hong Kong’s eHealth system.

The Government described this as a major milestone in regional healthcare integration.

Expansion of the “Hong Kong-Macau Medicines and Medical Devices Connect” Scheme

As of April 2026:

71 medicines and

91 medical devices

had been approved for use in designated GBA healthcare institutions, improving patient access to innovative treatments.

International Hospital Accreditation Standards

The Government also reported progress in implementing a new hospital accreditation framework jointly developed by Hong Kong and Mainland experts:

Five Hospital Authority hospitals have already received accreditation.

Two additional major acute hospitals are expected to join in 2026/27.

Nationwide, approximately 13 hospitals have obtained certification.

Key Issues Raised by Members

Satisfaction with the Elderly Health Care Voucher Scheme

While overall user satisfaction remains high at 9.15 out of 10, Members highlighted concerns about patient experience.

Common feedback included:

Limited Cantonese-language support at some facilities.

Difficulties navigating Mainland appointment systems.

Confusion over medication names.

Voucher payment procedures being more complicated than local electronic payment methods.

Two complaints remain under investigation, although the Government indicated they relate primarily to service procedures and communication rather than clinical quality.

Calls for Expansion Beyond the GBA

Several Members proposed extending the voucher scheme to other regions popular among Hong Kong residents, including:

Hainan's Boao Medical Pilot Zone.

Fujian Province.

The Government stated that future expansion would depend on population distribution, service demand and administrative considerations. While no timetable was announced, further reviews remain possible.

Cross-Boundary Ambulance Services

Members called for expansion to additional cities such as Dongguan, Zhongshan and Foshan, and asked whether private ambulance operators could participate.

The Government clarified that the existing scheme is a hospital-to-hospital transfer service, not an emergency ambulance service for cross-border emergencies. Patients must already be receiving treatment, be clinically stable and be assessed as suitable for transfer.

Authorities are reviewing future expansion and exploring the feasibility of involving private ambulance providers, though regulatory and licensing challenges remain.

Use of GBA Resources to Relieve Pressure on Hong Kong’s Healthcare System

Members suggested greater use of GBA medical resources, including expanding services at HKU-Shenzhen Hospital and exploring cross-boundary radiology services.

The Secretary for Health stressed that Hong Kong has no intention of transferring its healthcare responsibilities to other cities. Cross-boundary healthcare is intended to provide additional options and convenience for residents rather than replace Hong Kong’s healthcare system.

Cross-boundary procurement of diagnostic imaging services is still under review, particularly regarding quality standards, reporting qualifications and regulatory requirements.

Development of Innovative Medicines and Medical Devices

Industry representatives raised concerns over inconsistent documentation requirements and manpower shortages for regulatory inspections.

The Government responded that:

A dedicated Centre for Medical Products Regulation is being established.

Recruitment of regulatory professionals is being accelerated.

Hong Kong aims to strengthen its position as an international healthcare and medical innovation hub.

Hong Kong Patients Purchasing Medicines in Mainland China

Members noted that some cancer and rare disease patients travel to Mainland China to purchase medicines due to price differences.

The Government stated that seeking treatment or purchasing medicines in the Mainland remains a personal choice. Hong Kong doctors may provide medical records, but prescriptions for medicine purchases must comply with the respective legal and regulatory frameworks of both jurisdictions.

Overall Conclusions

The discussion reflected broad support for the Government’s direction on Greater Bay Area healthcare cooperation. Several major initiatives—including the Elderly Health Care Voucher Scheme, HKU-Shenzhen Hospital programme, cross-boundary ambulance transfers and cross-boundary health record sharing—were viewed positively by Members.

Four key policy messages emerged:

Greater Bay Area healthcare collaboration continues to expand and mature.

Cross-boundary healthcare is intended to complement, not replace, Hong Kong’s healthcare system.

Further expansion of the Elderly Health Care Voucher Scheme remains a major area of interest.

The next phase of integration will focus on deeper cooperation in health records, innovative medicines and medical devices, and cross-boundary patient transfer services.

Overall, the Government signalled its commitment to strengthening healthcare connectivity across the Greater Bay Area while maintaining Hong Kong’s responsibility for delivering healthcare services to its own residents.

持續跟進政策動向

Madison 將繼續密切跟進立法會衞生事務委員會的不同議程進展，並就相關醫療政策對業界的影響作深入分析。如欲了解更多資訊，或就相關議題作進一步交流，歡迎與我們聯絡。

Ongoing Monitoring of Policy Developments

Madison will continue to closely track the progress of various items before the LegCo Panel on Health Services and provide in‑depth analysis of the implications for the healthcare sector. For further information or to discuss any of the above topics, please feel free to contact us.